Par Drugs and Chemicals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 195.95 million compared to INR 171.67 million a year ago. Revenue was INR 196.23 million compared to INR 171.97 million a year ago. Net income was INR 22.2 million compared to INR 35.06 million a year ago. Basic earnings per share from continuing operations was INR 1.8 compared to INR 2.85 a year ago. Diluted earnings per share from continuing operations was INR 1.8 compared to INR 2.85 a year ago.
For the six months, sales was INR 360.78 million compared to INR 282.67 million a year ago. Revenue was INR 361.43 million compared to INR 283.22 million a year ago. Net income was INR 46.76 million compared to INR 51.11 million a year ago. Basic earnings per share from continuing operations was INR 3.8 compared to INR 4.155 a year ago. Diluted earnings per share from continuing operations was INR 3.8 compared to INR 4.155 a year ago.